Navi Mumbai has entered a new era of cancer treatment with the launch of Apollo Hospitals Navi Mumbai’s Precision Oncology Clinic. This initiative focuses on genomics-led personalized cancer care, ensuring treatments are tailored to the unique biology of each patient rather than following a generic, “one-size-fits-all” approach.
The clinic’s advanced precision oncology program uses genomic profiling to map a patient’s cancer at a molecular level. By analyzing biomarkers, cancer subtype, age, lifestyle, comorbidities, and individual treatment goals, doctors can design highly personalized treatment strategies. This approach allows for the selection of therapies that are not only more effective but also safer and better tolerated.
Dr. Jyoti Bajpai, Lead Consultant – Medical & Precision Oncology, explained, “Genomics helps us understand the specific subtype of cancer a patient has. For example, breast cancer can be classified as Luminal A, Luminal B, Triple-Negative, or HER2-positive. Each subtype behaves differently and responds uniquely to therapy. Precision oncology empowers us to match the right drug, at the right dose, to the right patient, improving treatment outcomes and reducing side effects.”
Mr. Arunesh Punetha, Regional CEO – Western Region, emphasised the patient-centric vision of the clinic: “We are moving beyond a generic approach. Now, every patient receives care aligned with their biology, professional life, personal preferences, and broader life circumstances.”
The clinic integrates advanced genomic sequencing with targeted therapies and regular multidisciplinary tumor board reviews. Specialists from oncology, pathology, radiology, and supportive care collaborate to develop individualized treatment plans. This collaborative model ensures that each patient’s care is informed by the latest scientific evidence and clinical expertise.
Precision oncology also enables more predictable treatment outcomes. By tailoring therapies to a patient’s unique molecular profile, clinicians can minimize unnecessary exposure to ineffective drugs and reduce adverse reactions. Additionally, genomic insights can help identify patients who may benefit from emerging therapies, clinical trials, or immunotherapy, expanding treatment options that were previously unavailable.
Apollo Hospitals Navi Mumbai’s initiative marks a significant step forward in cancer care, combining cutting-edge science with compassionate, patient-focused care. By harnessing genomics and precision medicine, the hospital is not only improving survival rates but also enhancing quality of life for cancer patients.
As genomics-led cancer treatment becomes more accessible, Navi Mumbai patients can now benefit from highly personalized therapies that are safer, more effective, and tailored to their unique needs, setting a new benchmark for oncology care in the region.
Subscribe Deshwale on YouTube
